Nuvalent (NUVL) Assets Average (2021 - 2026)
Nuvalent (NUVL) posted Assets Average of $1.4 billion for Q1 2026, up 14.68% on a QoQ basis from $1.2 billion in Q4 2025, and up 22.08% year-over-year from $1.1 billion in Q1 2025.
Nuvalent (NUVL) Assets Average (2021 - 2026) Analysis & Trends
Nuvalent's Assets Average history runs 6 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- Quarterly Assets Average rose 22.08% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 22.08% YoY) and the FY2025 annual result came in at $1.3 billion, up 36.3% from the prior year.
- Assets Average was $1.4 billion for Q1 2026 at Nuvalent, up from $1.2 billion in the prior quarter.
- Across five years, Assets Average topped out at $1.4 billion in Q1 2026 and bottomed at $256.3 million in Q3 2022.
- A 5-year average of $729.3 million and a median of $691.8 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2024 — Assets Average surged 115.0% — and 2025, when it climbed 2.66%.
- Nuvalent's Assets Average stood at $366.0 million in 2022, then jumped by 58.12% to $578.7 million in 2023, then surged by 101.35% to $1.2 billion in 2024, then rose by 2.66% to $1.2 billion in 2025, then grew by 14.68% to $1.4 billion in 2026.
- Business Quant data shows NUVL's Assets Average at $1.4 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 1.37 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.37 Bn |
| Dec 31, 2025 | 1.20 Bn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | 1.17 Bn |
| Sep 30, 2024 | 932.04 Mn |
| Jun 30, 2024 | 691.85 Mn |
| Mar 31, 2024 | 720.43 Mn |
| Dec 31, 2023 | 578.73 Mn |
| Sep 30, 2023 | 433.51 Mn |
| Jun 30, 2023 | 451.47 Mn |
| Mar 31, 2023 | 471.72 Mn |
| Dec 31, 2022 | 366.01 Mn |
| Sep 30, 2022 | 256.29 Mn |
| Jun 30, 2022 | 270.03 Mn |
| Mar 31, 2022 | 285.43 Mn |
| Dec 31, 2021 | 300.90 Mn |
| Sep 30, 2021 | 225.74 Mn |